01—Abstract
Summary
Summary of the 8-K filed November 25, 2025. Cited figures are marked; the original filing is the authoritative source.
Illumina, Inc. (ILMN) disclosed in a Form 8-K filed November 25, 2025 that it completed a public offering of $500,000,000a aggregate principal amount of its 4.750% notes due 2030 (the "Notes").
The Notes accrue interest at 4.750% per annum, payable semi-annually, and mature on December 12, 2030. The offering was registered under a Form S-3 Registration Statement (File No. 333-281921). Illumina expects to use the net proceeds for general corporate purposes, which may include repaying its 5.800% notes due December 12, 2025, of which $500 millionb aggregate principal amount was outstanding as of September 28, 2025, and completing the proposed acquisition of SomaLogic, Inc., along with paying related fees and expenses.
The Notes were issued under an Indenture dated March 12, 2021 with U.S. Bank Trust Company, National Association, as trustee, and an officer's certificate establishing their terms. The filing also describes standard terms: Event of Default acceleration provisions and the Company's right to redeem the Notes in whole or in part at the redemption prices and on the terms set forth in the Notes. The filing itself contains no additional financial results or guidance.
02—Key points
Key Highlights
- Completed a public offering of $500,000,000 aggregate principal amount of 4.750% notes due December 12, 2030.
- Interest on the Notes is payable semi-annually at 4.750% per annum.
- Expected net proceeds are for general corporate purposes, which may include repaying $500 million of 5.800% notes due December 12, 2025.
- Proceeds may also fund the proposed acquisition of SomaLogic, Inc. and related fees and expenses.
- The Notes were issued under a 2021 Indenture with U.S. Bank Trust Company, National Association, as trustee, and are registered on Form S-3 (File No. 333-281921).
- The Company may redeem the Notes in whole or in part at its election, subject to the redemption prices and terms in the Notes.
- Exhibits include the Indenture, officer's certificate, form of Note, and a legal opinion from Cravath, Swaine & Moore LLP.
03—Questions
Frequently Asked Questions
How much debt did Illumina issue and when does it mature?
Illumina completed a public offering of $500,000,000 aggregate principal amount of 4.750% notes due December 12, 2030.
What will Illumina use the proceeds for?
The filing states the net proceeds are expected for general corporate purposes, which may include repaying its 5.800% notes due December 12, 2025 ($500 million outstanding as of September 28, 2025) and completing the proposed acquisition of SomaLogic, Inc., plus paying related fees and expenses.
How often do the Notes pay interest?
The Notes accrue interest at 4.750% per annum, payable semi-annually.
Can Illumina redeem the Notes early?
Yes. The Company may, at its election, redeem the Notes in whole or in part from time to time at the redemption prices and on the terms set forth in the Notes.
Under what agreement were the Notes issued?
The Notes were issued under an Indenture dated March 12, 2021 between Illumina and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee, together with an officer's certificate dated November 25, 2025 establishing the terms.
04—Continue